RBII OTC
Rising Biosciences, Inc.
1W: +0.0%
1M: +900.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -98.3%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$640K
+60.1% ▲
Total Liabilities
$2M
+11.1% ▲
Shareholders Equity
-$1M
+5.8% ▲
Cash & Investments
$48K
+6190.4% ▲
Total Debt
$1M
+11.6% ▲
Net Debt
$1M
+6.6% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2019 | FY2020 |
|---|---|---|
| — Assets — | ||
| Cash | $763 | $48K |
| Short-Term Investments | $0 | $0 |
| Cash & ST Investments | $763 | $48K |
| Net Receivables | $0 | $121K |
| Inventory | $0 | $40K |
| Other Current Assets | $0 | $0 |
| Total Current Assets | $763 | $209K |
| Property, Plant & Equip. | $302K | $274K |
| Goodwill & Intangibles | $0 | $0 |
| Long-Term Investments | $68K | $158K |
| Other Non-Current Assets | $30K | $0 |
| Total Non-Current Assets | $399K | $432K |
| Total Assets | $400K | $640K |
| — Liabilities — | ||
| Accounts Payable | $49K | $49K |
| Short-Term Debt | $946K | $1M |
| Deferred Revenue | $0 | $0 |
| Other Current Liabilities | $562K | $520K |
| Total Current Liabilities | $2M | $2M |
| Long-Term Debt | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 |
| Total Liabilities | $2M | $2M |
| — Equity — | ||
| Common Stock | $844K | $1M |
| Retained Earnings | -$2M | -$2M |
| Accumulated OCI | $409K | $427K |
| Total Stockholders Equity | -$1M | -$1M |
| Total Liabilities & Equity | $400K | $640K |
| — Key Metrics — | ||
| Total Debt | $946K | $1M |
| Net Debt | $946K | $1M |
| Total Investments | $68K | $158K |